Measurements of treatment response in childhood acute leukemia
Authors:
Open Access
- 1 January 2012
- journal article
- Published by Springer Nature in The Korean Journal of Hematology
- Vol. 47 (4) , 245-254
Abstract
Campana D, et al. Korean J Hematol. 2012 Dec;47(4):245-254. http://dx.doi.org/10.5045/kjh.2012.47.4.245Keywords
This publication has 93 references indexed in Scilit:
- A new method for high speed, sensitive detection of minimal residual diseaseCytometry Part A, 2011
- High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemiaBlood, 2011
- Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic ContinuumScience, 2011
- Immunologic minimal residual disease detection in acute lymphoblastic leukemia: A comparative approach to molecular testingBest Practice & Research Clinical Haematology, 2010
- Clinical significance of low levels of minimal residual disease at the end of remission induction therapy in childhood acute lymphoblastic leukemiaBlood, 2010
- Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trialThe Lancet Oncology, 2010
- Treating Childhood Acute Lymphoblastic Leukemia without Cranial IrradiationNew England Journal of Medicine, 2009
- Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group studyBlood, 2008
- Quantitative analysis of minimal residual disease predicts relapse in children with B-lineage acute lymphoblastic leukemia in DFCI ALL Consortium Protocol 95-01Blood, 2007
- The incidence and clinical significance of nucleophosmin mutations in childhood AMLBlood, 2007